• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Podocyte Glucocorticoid Receptor Expression and Treatment Outcome in Idiopathic Nephrotic Syndrome.

作者信息

van den Berge Bartholomeus T, Jansen Jitske, Wetzels Jack F M, Smeets Bart, Maas Rutger J

机构信息

Department of Nephrology, Radboudumc, Nijmegen, The Netherlands.

Department of Pathology, Radboudumc, Nijmegen, The Netherlands.

出版信息

Kidney Int Rep. 2025 Apr 20;10(7):2450-2452. doi: 10.1016/j.ekir.2025.04.034. eCollection 2025 Jul.

DOI:10.1016/j.ekir.2025.04.034
PMID:40677323
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12266189/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a507/12266189/46550cf6b06a/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a507/12266189/46550cf6b06a/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a507/12266189/46550cf6b06a/gr1.jpg

相似文献

1
Podocyte Glucocorticoid Receptor Expression and Treatment Outcome in Idiopathic Nephrotic Syndrome.足细胞糖皮质激素受体表达与特发性肾病综合征的治疗结果
Kidney Int Rep. 2025 Apr 20;10(7):2450-2452. doi: 10.1016/j.ekir.2025.04.034. eCollection 2025 Jul.
2
The Role of Glucocorticoid Receptors in Podocytes and Nephrotic Syndrome.糖皮质激素受体在足细胞及肾病综合征中的作用
Nucl Receptor Res. 2018;5. doi: 10.11131/2018/101323. Epub 2018 Apr 24.
3
Autoantibodies Targeting Nephrin in Podocytopathies.足细胞病相关的 Nephrin 自身抗体
N Engl J Med. 2024 Aug 1;391(5):422-433. doi: 10.1056/NEJMoa2314471. Epub 2024 May 25.
4
Loss of the podocyte glucocorticoid receptor exacerbates proteinuria after injury.足细胞糖皮质激素受体缺失加剧损伤后蛋白尿。
Sci Rep. 2017 Aug 29;7(1):9833. doi: 10.1038/s41598-017-10490-z.
5
Salvianolic acid A attenuates steroid resistant nephrotic syndrome through suPAR/uPAR-αvβ3 signaling Inhibition.丹酚酸 A 通过抑制 suPAR/uPAR-αvβ3 信号通路减轻激素耐药性肾病综合征。
J Ethnopharmacol. 2021 Oct 28;279:114351. doi: 10.1016/j.jep.2021.114351. Epub 2021 Jun 19.
6
Loss of Nup160 dysregulates Cdc42 in the podocytes of podocyte-specific Nup160 knockout mice.在足细胞特异性Nup160基因敲除小鼠的足细胞中，Nup160的缺失会使Cdc42失调。
Hum Mol Genet. 2025 Jun 18;34(13):1134-1145. doi: 10.1093/hmg/ddaf064.
7
The glomerular permeability factors in idiopathic nephrotic syndrome.特发性肾病综合征中的肾小球通透性因子
Pediatr Nephrol. 2016 Feb;31(2):207-15. doi: 10.1007/s00467-015-3082-x. Epub 2015 Apr 30.
8
The autoimmune architecture of childhood idiopathic nephrotic syndrome.儿童特发性肾病综合征的自身免疫结构
Kidney Int. 2025 Feb;107(2):271-279. doi: 10.1016/j.kint.2024.10.027. Epub 2024 Nov 19.
9
Activation of the IL-2 Receptor in Podocytes: A Potential Mechanism for Podocyte Injury in Idiopathic Nephrotic Syndrome?足细胞中白细胞介素-2受体的激活：特发性肾病综合征中足细胞损伤的潜在机制？
PLoS One. 2016 Jul 7;11(7):e0157907. doi: 10.1371/journal.pone.0157907. eCollection 2016.
10
Human pluripotent stem cell-derived kidney organoids for personalized congenital and idiopathic nephrotic syndrome modeling.用于个性化先天性和特发性肾病综合征建模的人多能干细胞衍生肾类器官
Development. 2022 May 1;149(9). doi: 10.1242/dev.200198. Epub 2022 May 6.

本文引用的文献

1
Management of adult patients with podocytopathies: an update from the ERA Immunonephrology Working Group.成人足细胞病的治疗：欧洲肾脏学会免疫肾脏病学工作组的最新进展。
Nephrol Dial Transplant. 2024 Mar 27;39(4):569-580. doi: 10.1093/ndt/gfae025.
2
Inhibition of the glucocorticoid receptor attenuates proteinuric kidney diseases in multiple species.抑制糖皮质激素受体可减轻多种物种的蛋白尿性肾脏疾病。
Nephrol Dial Transplant. 2024 Jun 28;39(7):1181-1193. doi: 10.1093/ndt/gfad254.
3
Later Response to Corticosteroids in Adults With Primary Focal Segmental Glomerular Sclerosis Is Associated With Favorable Outcomes.
成人原发性局灶节段性肾小球硬化症患者对皮质类固醇的延迟反应与良好预后相关。
Kidney Int Rep. 2021 Oct 29;7(1):87-98. doi: 10.1016/j.ekir.2021.10.016. eCollection 2022 Jan.
4
The podocyte as a direct target of glucocorticoids in nephrotic syndrome.足细胞是肾病综合征中糖皮质激素的直接作用靶点。
Nephrol Dial Transplant. 2022 Sep 22;37(10):1808-1815. doi: 10.1093/ndt/gfab016.
5
Pharmacology and pharmacogenetics of prednisone and prednisolone in patients with nephrotic syndrome.肾病综合征患者中泼尼松和泼尼松龙的药理学和药物遗传学。
Pediatr Nephrol. 2019 Mar;34(3):389-403. doi: 10.1007/s00467-018-3929-z. Epub 2018 Mar 16.
6
Minimal change disease and idiopathic FSGS: manifestations of the same disease.微小病变病和特发性 FSGS：同一种疾病的表现。
Nat Rev Nephrol. 2016 Dec;12(12):768-776. doi: 10.1038/nrneph.2016.147. Epub 2016 Oct 17.
7
Glomerular Glucocorticoid Receptors Expression and Clinicopathological Types of Childhood Nephrotic Syndrome.儿童肾病综合征肾小球糖皮质激素受体表达与临床病理类型
Fetal Pediatr Pathol. 2017 Feb;36(1):16-26. doi: 10.1080/15513815.2016.1225872. Epub 2016 Oct 3.
8
Glomerular glucocorticoid receptor expression is reduced in late responders to steroids in adult-onset minimal change disease.在成人起病的微小病变病中，对类固醇反应迟缓者的肾小球糖皮质激素受体表达降低。
Nephrol Dial Transplant. 2008 Jan;23(1):169-75. doi: 10.1093/ndt/gfm575. Epub 2007 Sep 22.
9
Focal and segmental glomerulosclerosis: definition and relevance of a partial remission.局灶节段性肾小球硬化：部分缓解的定义及相关性
J Am Soc Nephrol. 2005 Apr;16(4):1061-8. doi: 10.1681/ASN.2004070593. Epub 2005 Feb 16.